Logo image of MYD

BLACKROCK MUNIYIELD FUND (MYD) Stock Price, Quote, News and Overview

NYSE:MYD - New York Stock Exchange, Inc. - US09253W1045 - Currency: USD

10.77  +0.01 (+0.09%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MYD. MYD was compared to 0 industry peers in the Unkown industry. While MYD seems to be doing ok healthwise, there are quite some concerns on its profitability. MYD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MYD had negative earnings in the past year.
In multiple years MYD reported negative net income over the last 5 years.
Each year in the past 5 years MYD had a positive operating cash flow.
MYD Yearly Net Income VS EBIT VS OCF VS FCFMYD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

1.2 Ratios

Industry RankSector Rank
ROA -0.63%
ROE -0.68%
ROIC 1.97%
ROA(3y)0.24%
ROA(5y)0.48%
ROE(3y)0.21%
ROE(5y)0.5%
ROIC(3y)2.25%
ROIC(5y)2.33%
MYD Yearly ROA, ROE, ROICMYD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Operating Margin of MYD has declined.
In the last couple of years the Gross Margin of MYD has declined.
Industry RankSector Rank
OM 58.43%
PM (TTM) N/A
GM 59.49%
OM growth 3Y-5.12%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.02%
GM growth 5Y-4.24%
MYD Yearly Profit, Operating, Gross MarginsMYD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

More info and screens

4

2. Health

2.1 Basic Checks

MYD has less shares outstanding than it did 1 year ago.
MYD has less shares outstanding than it did 5 years ago.
MYD has a better debt/assets ratio than last year.
MYD Yearly Shares OutstandingMYD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MYD Yearly Total Debt VS Total AssetsMYD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 4.55 indicates that MYD is not in any danger for bankruptcy at the moment.
MYD has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 4.55
ROIC/WACCN/A
WACCN/A
MYD Yearly LT Debt VS Equity VS FCFMYD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.45 indicates that MYD should not have too much problems paying its short term obligations.
A Quick Ratio of 1.45 indicates that MYD should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
MYD Yearly Current Assets VS Current LiabilitesMYD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

MYD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.97%, which is quite impressive.
The Revenue has decreased by -5.96% in the past year.
Measured over the past years, MYD shows a decrease in Revenue. The Revenue has been decreasing by -6.18% on average per year.
EPS 1Y (TTM)93.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%383.78%
Revenue 1Y (TTM)-5.96%
Revenue growth 3Y-6.72%
Revenue growth 5Y-6.18%
Sales Q2Q%2.95%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYD Yearly Revenue VS EstimatesMYD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
MYD Yearly EPS VS EstimatesMYD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MYD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYD Price Earnings VS Forward Price EarningsMYD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYD Per share dataMYD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.45%, MYD is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.27, MYD pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.45%

5.2 History

The dividend of MYD decreases each year by -7.19%.
MYD has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of MYD decreased recently.
Dividend Growth(5Y)-7.19%
Div Incr Years1
Div Non Decr Years1
MYD Yearly Dividends per shareMYD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

MYD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-219.42%
EPS Next 2YN/A
EPS Next 3YN/A
MYD Yearly Income VS Free CF VS DividendMYD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

More info and screens

BLACKROCK MUNIYIELD FUND

NYSE:MYD (2/21/2025, 8:04:00 PM)

10.77

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)04-01 2025-04-01
Inst Owners29.6%
Inst Owner Change5.77%
Ins OwnersN/A
Ins Owner Change0.13%
Market Cap492.51M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 5.45%
Yearly Dividend0.54
Dividend Growth(5Y)-7.19%
DP-219.42%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-14 2025-02-14 (0.0545)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.35
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.81
BVpS17.76
TBVpS17.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.63%
ROE -0.68%
ROCE 2.5%
ROIC 1.97%
ROICexc 1.99%
ROICexgc 1.99%
OM 58.43%
PM (TTM) N/A
GM 59.49%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.48%
ROE(3y)0.21%
ROE(5y)0.5%
ROIC(3y)2.25%
ROIC(5y)2.33%
ROICexc(3y)2.25%
ROICexc(5y)2.33%
ROICexgc(3y)2.25%
ROICexgc(5y)2.33%
ROCE(3y)2.85%
ROCE(5y)2.95%
ROICexcg growth 3Y-5.01%
ROICexcg growth 5Y-5.14%
ROICexc growth 3Y-5.01%
ROICexc growth 5Y-5.14%
OM growth 3Y-5.12%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.02%
GM growth 5Y-4.24%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z 4.55
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%383.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.96%
Revenue growth 3Y-6.72%
Revenue growth 5Y-6.18%
Sales Q2Q%2.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.7%
EBIT growth 3Y-11.5%
EBIT growth 5Y-10.2%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y211.2%
FCF growth 3Y81.25%
FCF growth 5Y24.38%
OCF growth 1Y211.2%
OCF growth 3Y81.25%
OCF growth 5Y24.38%